Rohan Gosavi

Interleukin Inhibitors Market: Paving the Way for Advanced Therapeutics in Autoimmune and Inflammatory Diseases

Interleukin Inhibitors Market: Paving the Way for Advanced Therapeutics in Autoimmune and Inflammatory Diseases

Market Overview The Interleukin Inhibitors Market is experiencing significant growth, driven by the increasing prevalence of autoimmune diseases, inflammatory disorders, and the growing need for advanced therapeutic options. Interleukin (IL) inhibitors are a class of biologic drugs that specifically target and block the action of interleukins, which are cytokines involved

By Rohan Gosavi